OTC Labeling: FDA "Sensitive" To UPC Code Issues, Agency's Bowen Says

FDA is considering omitting the space needed for a properly sized Uniform Product Code symbol from the calculation of whether an OTC package is exempt from the type size requirements of the OTC labeling final rule, FDA ODE V Deputy Director Debra Bowen, MD, and Division of OTC Drugs Director Charles Ganley, MD, said at an OTC labeling "feedback" meeting in Rockville, Md. June 29.